Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci.

PubWeight™: 2.21‹?› | Rank: Top 2%

🔗 View Article (PMC 3026436)

Published in Cell Metab on November 03, 2010

Authors

Michael L Stitzel1, Praveen Sethupathy, Daniel S Pearson, Peter S Chines, Lingyun Song, Michael R Erdos, Ryan Welch, Stephen C J Parker, Alan P Boyle, Laura J Scott, NISC Comparative Sequencing Program, Elliott H Margulies, Michael Boehnke, Terrence S Furey, Gregory E Crawford, Francis S Collins

Author Affiliations

1: Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Articles citing this

Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Res (2011) 4.43

Identifying ChIP-seq enrichment using MACS. Nat Protoc (2012) 3.60

ChIP-seq and beyond: new and improved methodologies to detect and characterize protein-DNA interactions. Nat Rev Genet (2012) 3.23

Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc Natl Acad Sci U S A (2013) 2.93

Epigenomic plasticity enables human pancreatic α to β cell reprogramming. J Clin Invest (2013) 2.38

Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants. Nat Genet (2014) 2.38

Enhancer RNAs and regulated transcriptional programs. Trends Biochem Sci (2014) 1.85

Essential role for miR-196a in brown adipogenesis of white fat progenitor cells. PLoS Biol (2012) 1.53

Transcriptional enhancers in development and disease. Genome Biol (2012) 1.52

Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. Genome Res (2011) 1.50

β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. Diabetes Care (2014) 1.42

Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism. Proc Natl Acad Sci U S A (2014) 1.40

Discovery of active enhancers through bidirectional expression of short transcripts. Genome Biol (2011) 1.34

PPARγ and the global map of adipogenesis and beyond. Trends Endocrinol Metab (2014) 1.26

Global mapping of cell type-specific open chromatin by FAIRE-seq reveals the regulatory role of the NFI family in adipocyte differentiation. PLoS Genet (2011) 1.24

Chromatin immunoprecipitation and high-throughput sequencing from paraffin-embedded pathology tissue. Nat Protoc (2011) 1.15

miR-182 and miR-10a are key regulators of Treg specialisation and stability during Schistosome and Leishmania-associated inflammation. PLoS Pathog (2013) 1.11

TCF7L2 is a master regulator of insulin production and processing. Hum Mol Genet (2014) 1.10

Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentials. Crit Rev Eukaryot Gene Expr (2011) 1.09

Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4. Diabetologia (2013) 1.07

Epigenetic modifications in the pathogenesis of diabetic nephropathy. Semin Nephrol (2013) 1.02

Genome-wide analysis of the relationships between DNaseI HS, histone modifications and gene expression reveals distinct modes of chromatin domains. Nucleic Acids Res (2011) 1.01

Genome-wide localization of protein-DNA binding and histone modification by a Bayesian change-point method with ChIP-seq data. PLoS Comput Biol (2012) 0.98

An alternative polyadenylation signal in TCF7L2 generates isoforms that inhibit T cell factor/lymphoid-enhancer factor (TCF/LEF)-dependent target genes. Diabetologia (2011) 0.96

Identification and analysis of murine pancreatic islet enhancers. Diabetologia (2012) 0.96

Enhancer variants: evaluating functions in common disease. Genome Med (2014) 0.95

In vitro scan for enhancers at the TCF7L2 locus. Diabetologia (2012) 0.95

DNA shape, genetic codes, and evolution. Curr Opin Struct Biol (2011) 0.94

Allele-specific transcriptional activity at type 2 diabetes-associated single nucleotide polymorphisms in regions of pancreatic islet open chromatin at the JAZF1 locus. Diabetes (2013) 0.94

Centenarians as super-controls to assess the biological relevance of genetic risk factors for common age-related diseases: a proof of principle on type 2 diabetes. Aging (Albany NY) (2013) 0.94

Prioritization of genetic variants in the microRNA regulome as functional candidates in genome-wide association studies. Hum Mutat (2013) 0.92

Developmental and environmental epigenetic programming of the endocrine pancreas: consequences for type 2 diabetes. Cell Mol Life Sci (2013) 0.91

An in vivo cis-regulatory screen at the type 2 diabetes associated TCF7L2 locus identifies multiple tissue-specific enhancers. PLoS One (2012) 0.90

β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. J Clin Endocrinol Metab (2014) 0.90

Identification of a regulatory variant that binds FOXA1 and FOXA2 at the CDC123/CAMK1D type 2 diabetes GWAS locus. PLoS Genet (2014) 0.89

A common functional regulatory variant at a type 2 diabetes locus upregulates ARAP1 expression in the pancreatic beta cell. Am J Hum Genet (2014) 0.88

TCF7L2 and glucose metabolism: time to look beyond the pancreas. Diabetes (2013) 0.87

Epigenetics and diabetes treatment: an unrealized promise? Trends Endocrinol Metab (2012) 0.87

Functional implications of long non-coding RNAs in the pancreatic islets of Langerhans. Front Genet (2014) 0.87

Reduction in Tcf7l2 expression decreases diabetic susceptibility in mice. Int J Biol Sci (2012) 0.85

Epigenetic understanding of gene-environment interactions in psychiatric disorders: a new concept of clinical genetics. Clin Epigenetics (2012) 0.84

What will diabetes genomes tell us? Curr Diab Rep (2012) 0.84

Recent progress in genetic and epigenetic research on type 2 diabetes. Exp Mol Med (2016) 0.83

Evidence of non-pancreatic beta cell-dependent roles of Tcf7l2 in the regulation of glucose metabolism in mice. Hum Mol Genet (2014) 0.83

Diabetes Susceptibility Genes Pdx1 and Clec16a Function in a Pathway Regulating Mitophagy in β-Cells. Diabetes (2015) 0.82

Transcriptional and epigenetic regulation in human islets. Diabetologia (2013) 0.82

Identifying novel transcriptional components controlling energy metabolism. Cell Metab (2011) 0.82

Type 2 diabetes: genetic data sharing to advance complex disease research. Nat Rev Genet (2016) 0.82

Type 2 Diabetes-Associated K+ Channel TALK-1 Modulates β-Cell Electrical Excitability, Second-Phase Insulin Secretion, and Glucose Homeostasis. Diabetes (2015) 0.81

Creating new β cells: cellular transmutation by genomic alchemy. J Clin Invest (2013) 0.81

Novel pancreatic endocrine maturation pathways identified by genomic profiling and causal reasoning. PLoS One (2013) 0.80

The pancreatic β cell: recent insights from human genetics. Trends Endocrinol Metab (2014) 0.80

Epigenetic regulation of pancreas development and function. Semin Cell Dev Biol (2012) 0.79

Human genetic variation within neural crest enhancers: molecular and phenotypic implications. Philos Trans R Soc Lond B Biol Sci (2013) 0.79

Profiling of embryonic stem cell differentiation. Rev Diabet Stud (2014) 0.79

Common and rare forms of diabetes mellitus: towards a continuum of diabetes subtypes. Nat Rev Endocrinol (2016) 0.78

Epigenetic modifications and long noncoding RNAs influence pancreas development and function. Trends Genet (2015) 0.78

Redundant enhancers and causal variants in the TCF7L2 gene. Eur J Hum Genet (2014) 0.78

Translational implications of the β-cell epigenome in diabetes mellitus. Transl Res (2014) 0.77

Organogenesis and functional genomics of the endocrine pancreas. Cell Mol Life Sci (2012) 0.77

Illuminating microRNA Transcription from the Epigenome. Curr Genomics (2013) 0.77

Detection of type 2 diabetes related modules and genes based on epigenetic networks. BMC Syst Biol (2014) 0.77

A novel Bayesian change-point algorithm for genome-wide analysis of diverse ChIPseq data types. J Vis Exp (2012) 0.77

Mechanisms of Type 2 Diabetes Risk Loci. Curr Diab Rep (2017) 0.76

Environmental contaminants and microRNA regulation: Transcription factors as regulators of toxicant-altered microRNA expression. Toxicol Appl Pharmacol (2016) 0.76

The Importance of Context: Uncovering Species- and Tissue-Specific Effects of Genetic Risk Variants for Type 2 Diabetes. Front Endocrinol (Lausanne) (2016) 0.76

Epigenetic modifications and diabetic nephropathy. Kidney Res Clin Pract (2012) 0.76

A systems view of epigenetic networks regulating pancreas development and β-cell function. Wiley Interdiscip Rev Syst Biol Med (2015) 0.76

Genetic associations of type 2 diabetes with islet amyloid polypeptide processing and degrading pathways in asian populations. PLoS One (2013) 0.76

Wnt9a deficiency discloses a repressive role of Tcf7l2 on endocrine differentiation in the embryonic pancreas. Sci Rep (2016) 0.75

Hypergeometric analysis of tiling-array and sequence data: detection and interpretation of peaks. Adv Appl Bioinform Chem (2013) 0.75

The Pancreatic Islet Regulome Browser. Front Genet (2017) 0.75

DNase I aggravates islet β-cell apoptosis in type 2 diabetes. Mol Med Rep (2016) 0.75

Transcriptional Regulation of the Pancreatic Islet: Implications for Islet Function. Curr Diab Rep (2015) 0.75

Epigenetic Combinatorial Patterns Predict Disease Variants. Front Genet (2017) 0.75

Articles cited by this

High-resolution profiling of histone methylations in the human genome. Cell (2007) 85.74

Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09

Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature (2007) 65.18

Chromatin modifications and their function. Cell (2007) 55.98

Model-based analysis of ChIP-Seq (MACS). Genome Biol (2008) 51.63

Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res (2005) 44.08

Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol (1994) 37.96

Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet (2007) 32.41

The role of chromatin during transcription. Cell (2007) 26.48

Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature (2009) 24.41

A chromatin landmark and transcription initiation at most promoters in human cells. Cell (2007) 23.41

Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet (2008) 18.28

The mammalian epigenome. Cell (2007) 18.13

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome. Cell (2007) 16.66

Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet (2009) 16.53

Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell (2008) 16.38

High-resolution mapping and characterization of open chromatin across the genome. Cell (2008) 15.93

CTCF: master weaver of the genome. Cell (2009) 15.09

Variants in MTNR1B influence fasting glucose levels. Nat Genet (2008) 10.85

Global mapping of protein-DNA interactions in vivo by digital genomic footprinting. Nat Methods (2009) 10.17

Genome-wide identification of in vivo protein-DNA binding sites from ChIP-Seq data. Nucleic Acids Res (2008) 8.89

FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Res (2006) 7.72

Global analysis of the insulator binding protein CTCF in chromatin barrier regions reveals demarcation of active and repressive domains. Genome Res (2008) 7.41

A map of open chromatin in human pancreatic islets. Nat Genet (2010) 6.75

Mechanisms of disease:Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol (2008) 6.23

Identification and characterization of cell type-specific and ubiquitous chromatin regulatory structures in the human genome. PLoS Genet (2007) 5.93

In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat Genet (2003) 5.10

Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest (2007) 5.02

Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet (2008) 4.84

Genome-wide computational prediction of transcriptional regulatory modules reveals new insights into human gene expression. Genome Res (2006) 4.32

Local DNA topography correlates with functional noncoding regions of the human genome. Science (2009) 4.18

Genome-wide relationship between histone H3 lysine 4 mono- and tri-methylation and transcription factor binding. Genome Res (2008) 4.11

Discovery of functional noncoding elements by digital analysis of chromatin structure. Proc Natl Acad Sci U S A (2004) 3.59

DNase-seq: a high-resolution technique for mapping active gene regulatory elements across the genome from mammalian cells. Cold Spring Harb Protoc (2010) 3.54

Statistics for ChIP-chip and DNase hypersensitivity experiments on NimbleGen arrays. Methods Enzymol (2006) 3.53

Identifying gene regulatory elements by genome-wide recovery of DNase hypersensitive sites. Proc Natl Acad Sci U S A (2004) 3.41

Type 2 diabetes: new genes, new understanding. Trends Genet (2008) 3.35

On the origin of the beta cell. Genes Dev (2008) 3.34

Finding distal regulatory elements in the human genome. Curr Opin Genet Dev (2009) 3.02

A novel susceptibility locus for type 1 diabetes on Chr12q13 identified by a genome-wide association study. Diabetes (2008) 2.90

The replication of beta cells in normal physiology, in disease and for therapy. Nat Clin Pract Endocrinol Metab (2007) 2.72

Long-range chromosomal interactions and gene regulation. Mol Biosyst (2008) 2.56

Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes (2010) 2.44

Human RNA polymerase III transcriptomes and relationships to Pol II promoter chromatin and enhancer-binding factors. Nat Struct Mol Biol (2010) 2.30

Chromatin poises miRNA- and protein-coding genes for expression. Genome Res (2009) 2.28

PReMod: a database of genome-wide mammalian cis-regulatory module predictions. Nucleic Acids Res (2006) 2.27

Regulation of insulin gene transcription. Semin Cell Dev Biol (2000) 1.63

Detailed transcriptome atlas of the pancreatic beta cell. BMC Med Genomics (2009) 1.55

Quantitative differential expression analysis reveals miR-7 as major islet microRNA. Biochem Biophys Res Commun (2007) 1.54

Genome-wide analysis of histone modifications in human pancreatic islets. Genome Res (2010) 1.51

A closer look at long-range chromosomal interactions. Trends Biochem Sci (2003) 1.50

Meta-regulation: microRNA regulation of glucose and lipid metabolism. Trends Endocrinol Metab (2009) 1.49

MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas. Gene Expr Patterns (2008) 1.24

The human insulin gene is part of a large open chromatin domain specific for human islets. Proc Natl Acad Sci U S A (2009) 1.17

Novel biological insights emerging from genetic studies of type 2 diabetes and related metabolic traits. Curr Opin Lipidol (2010) 1.13

Promoter elements in endocrine pancreas development and hormone regulation. Cell Mol Life Sci (2003) 0.83

Articles by these authors

The human genome browser at UCSC. Genome Res (2002) 168.23

Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15

A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39

Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09

Finding the missing heritability of complex diseases. Nature (2009) 67.95

Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A (2009) 54.68

A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science (2007) 43.16

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06

Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet (2007) 32.41

Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21

Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet (2008) 25.83

The UCSC Table Browser data retrieval tool. Nucleic Acids Res (2004) 25.12

Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature (2009) 24.41

Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature (2004) 24.40

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

LAGAN and Multi-LAGAN: efficient tools for large-scale multiple alignment of genomic DNA. Genome Res (2003) 23.03

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35

Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet (2008) 20.66

Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A (2002) 20.48

International network of cancer genome projects. Nature (2010) 20.35

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet (2011) 18.88

Distribution and intensity of constraint in mammalian genomic sequence. Genome Res (2005) 18.85

A HapMap harvest of insights into the genetics of common disease. J Clin Invest (2008) 18.31

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet (2006) 17.36

Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96

The accessible chromatin landscape of the human genome. Nature (2012) 16.86

Identification of ten loci associated with height highlights new biological pathways in human growth. Nat Genet (2008) 16.25

Replicating genotype-phenotype associations. Nature (2007) 16.11

Topographical and temporal diversity of the human skin microbiome. Science (2009) 15.96

Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94

High-resolution mapping and characterization of open chromatin across the genome. Cell (2008) 15.93

Policy: NIH plans to enhance reproducibility. Nature (2014) 15.71

New models of collaboration in genome-wide association studies: the Genetic Association Information Network. Nat Genet (2007) 13.76

LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics (2010) 13.54

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44

Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell (2012) 12.32

Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature (2003) 12.10

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10

Covariation in frequencies of substitution, deletion, transposition, and recombination during eutherian evolution. Genome Res (2003) 11.12

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09

Variants in MTNR1B influence fasting glucose levels. Nat Genet (2008) 10.85